DESIGNMEDIX, INC.

PORTLAND, OR · Founded 2008 · Biotech · Defunct

Novel nitro-heterocyclic antimicrobial compounds for treating drug-resistant Trichomonas vaginalis infections

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Biotech
Headquarters: PORTLAND, OR
Founded: 2008
Latest Form D: $651K, Apr 2017
Total capital: $4.6M

Federal grants: $2.3M; 3 awards · 2015–2016; Rank in peer group#461 of 514
Private capital raised: $2.2M; 3 Form D · last Apr 2017; 115 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 0; 1 pending

Capital timeline

Latest events

Apr 2017Private capital raisedForm D · SEC · 3rd filing$651K
Mar 2016Federal grantHealth and Human S · Phase II · Preclinical development of novel small molecule malaria drugs that overcome drug$994K
Feb 2016Federal grantHealth and Human S · Phase I · High-potency nitro antimicrobials for topical treatment of trichomoniasis$354K
Mar 2015Federal grantHealth and Human S · Phase II · Preclinical development of novel small molecule malaria drugs that overcome drug$1.0M
Jul 2013Private capital raisedForm D · SEC · 2nd filing$525K
Apr 2009Private capital raisedForm D · SEC · 1st filing$1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 514 peers

Line = median

Biotech · Molecule

Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

David Lee PeytonResearcherExecutive Officer, DirectorLinked by $2.3M in grants as PI
Erik Robert IversonDirectorNamed in SEC Form D filings
James Lee WilsonDirectorNamed in SEC Form D filings
Joseph Robert JarzembowskiDirectorNamed in SEC Form D filings
Lynnor B. StevensonExecutive Officer, Director, PromoterNamed in SEC Form D filings
Sandra Lee ShotwellExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 1

PendingModified Fluoroquinolone Compounds And Methods Of UsingUSPTOApplication PCTUS2010048996

Mariana OncologySimilar federal contract value in Biotech · null in contracts
TURTLETREE LABS INC.Similar federal contract value in Biotech · null in contracts
Denali TherapeuticsSimilar federal contract value in Biotech · null in contracts
MS Biotech Holdings, Inc.Similar federal contract value in Biotech · null in contracts
PROLACTA BIOSCIENCE INCSimilar federal contract value in Biotech · null in contracts
CalciMedica Subsidiary, Inc.Similar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.